These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33951425)

  • 1. Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
    Seydoux E; Wan YH; Feng J; Wall A; Aljedani S; Homad LJ; MacCamy AJ; Weidle C; Gray MD; Brumage L; Taylor JJ; Pancera M; Stamatatos L; McGuire AT
    Cell Rep; 2021 May; 35(5):109084. PubMed ID: 33951425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.
    Havenar-Daughton C; Sarkar A; Kulp DW; Toy L; Hu X; Deresa I; Kalyuzhniy O; Kaushik K; Upadhyay AA; Menis S; Landais E; Cao L; Diedrich JK; Kumar S; Schiffner T; Reiss SM; Seumois G; Yates JR; Paulson JC; Bosinger SE; Wilson IA; Schief WR; Crotty S
    Sci Transl Med; 2018 Jul; 10(448):. PubMed ID: 29973404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
    Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
    Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.
    Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR
    Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
    Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational HIV immunogen design to target specific germline B cell receptors.
    Jardine J; Julien JP; Menis S; Ota T; Kalyuzhniy O; McGuire A; Sok D; Huang PS; MacPherson S; Jones M; Nieusma T; Mathison J; Baker D; Ward AB; Burton DR; Stamatatos L; Nemazee D; Wilson IA; Schief WR
    Science; 2013 May; 340(6133):711-6. PubMed ID: 23539181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.
    Lin YR; Parks KR; Weidle C; Naidu AS; Khechaduri A; Riker AO; Takushi B; Chun JH; Borst AJ; Veesler D; Stuart A; Agrawal P; Gray M; Pancera M; Huang PS; Stamatatos L
    Immunity; 2020 Oct; 53(4):840-851.e6. PubMed ID: 33053332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
    LaBranche CC; McGuire AT; Gray MD; Behrens S; Kwong PDK; Chen X; Zhou T; Sattentau QJ; Peacock J; Eaton A; Greene K; Gao H; Tang H; Perez LG; Chen X; Saunders KO; Kwong PD; Mascola JR; Haynes BF; Stamatatos L; Montefiori DC
    PLoS Pathog; 2018 Nov; 14(11):e1007431. PubMed ID: 30395637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.
    Chen X; Zhou T; Schmidt SD; Duan H; Cheng C; Chuang GY; Gu Y; Louder MK; Lin BC; Shen CH; Sheng Z; Zheng MX; Doria-Rose NA; Joyce MG; Shapiro L; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2021 Feb; 54(2):324-339.e8. PubMed ID: 33453152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Huang D; Abbott RK; Havenar-Daughton C; Skog PD; Al-Kolla R; Groschel B; Blane TR; Menis S; Tran JT; Thinnes TC; Volpi SA; Liguori A; Schiffner T; Villegas SM; Kalyuzhniy O; Pintea M; Voss JE; Phelps N; Tingle R; Rodriguez AR; Martin G; Kupryianov S; deCamp A; Schief WR; Nemazee D; Crotty S
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22920-22931. PubMed ID: 32873644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier.
    Bonsignori M; Scott E; Wiehe K; Easterhoff D; Alam SM; Hwang KK; Cooper M; Xia SM; Zhang R; Montefiori DC; Henderson R; Nie X; Kelsoe G; Moody MA; Chen X; Joyce MG; Kwong PD; Connors M; Mascola JR; McGuire AT; Stamatatos L; Medina-Ramírez M; Sanders RW; Saunders KO; Kepler TB; Haynes BF
    Immunity; 2018 Dec; 49(6):1162-1174.e8. PubMed ID: 30552024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.
    McGuire AT
    Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site.
    Caniels TG; Medina-Ramìrez M; Zhang S; Kratochvil S; Xian Y; Koo JH; Derking R; Samsel J; van Schooten J; Pecetta S; Lamperti E; Yuan M; Carrasco MR; Del Moral Sánchez I; Allen JD; Bouhuijs JH; Yasmeen A; Ketas TJ; Snitselaar JL; Bijl TPL; Martin IC; Torres JL; Cupo A; Shirreff L; Rogers K; Mason RD; Roederer M; Greene KM; Gao H; Silva CM; Baken IJL; Tian M; Alt FW; Pulendran B; Seaman MS; Crispin M; van Gils MJ; Montefiori DC; McDermott AB; Villinger FJ; Koup RA; Moore JP; Klasse PJ; Ozorowski G; Batista FD; Wilson IA; Ward AB; Sanders RW
    Sci Immunol; 2024 Aug; 9(98):eadk9550. PubMed ID: 39213338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.
    Sok D; Briney B; Jardine JG; Kulp DW; Menis S; Pauthner M; Wood A; Lee EC; Le KM; Jones M; Ramos A; Kalyuzhniy O; Adachi Y; Kubitz M; MacPherson S; Bradley A; Friedrich GA; Schief WR; Burton DR
    Science; 2016 Sep; 353(6307):1557-1560. PubMed ID: 27608668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses.
    Dosenovic P; Pettersson AK; Wall A; Thientosapol ES; Feng J; Weidle C; Bhullar K; Kara EE; Hartweger H; Pai JA; Gray MD; Parks KR; Taylor JJ; Pancera M; Stamatatos L; Nussenzweig MC; McGuire AT
    J Exp Med; 2019 Oct; 216(10):2316-2330. PubMed ID: 31345931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.
    McGuire AT; Hoot S; Dreyer AM; Lippy A; Stuart A; Cohen KW; Jardine J; Menis S; Scheid JF; West AP; Schief WR; Stamatatos L
    J Exp Med; 2013 Apr; 210(4):655-63. PubMed ID: 23530120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
    Elife; 2016 Mar; 5():. PubMed ID: 26997349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
    Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
    PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env.
    Agrawal P; Knudsen ML; MacCamy A; Hurlburt NK; Khechaduri A; Salladay KR; Kher GM; Kallur Siddaramaiah L; Stuart AB; Bontjer I; Shen X; Montefiori D; Gristick HB; Bjorkman PJ; Sanders RW; Pancera M; Stamatatos L
    J Virol; 2024 Oct; 98(10):e0074424. PubMed ID: 39240111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.
    Cottrell CA; Hu X; Lee JH; Skog P; Luo S; Flynn CT; McKenney KR; Hurtado J; Kalyuzhniy O; Liguori A; Willis JR; Landais E; Raemisch S; Chen X; Baboo S; Himansu S; Diedrich JK; Duan H; Cheng C; Schiffner T; Bader DLV; Kulp DW; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Sincomb T; Kubitz M; Mullen TM; Yates JR; Paulson JC; Mascola JR; Alt FW; Briney B; Sok D; Schief WR
    Sci Transl Med; 2024 May; 16(748):eadn0223. PubMed ID: 38753806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.